Scientific Advisory Committee
- Emeritus Professor Thomas John Martin
- Professor John W Eaton
- Professor Simon Charles Gandevia
- Professor Robert M Graham
Emeritus Professor Thomas John Martin, AO, FAA, FRS, MBBS (Melbourne), MD (Melbourne), DSc (Melbourne), MRACP, FRACP, FRCPA, Hon MD (Sheffield).
Professor Martin is Emeritus Professor of Medicine at the University of Melbourne, and John Holt Fellow associated with St Vincent's Institute of Medical Research. His previous appointments have included: Director, St Vincent's Institute of Medical Research, University of Melbourne; Professor of Medicine and Chairman, University of Melbourne Department of Medicine, St Vincent's Hospital, Melbourne; Professor of Medicine and Chairman, University of Melbourne Department of Medicine, Austin and Repatriation General Hospitals, Heidelberg, Melbourne; Professor of Chemical Pathology, University of Sheffield, UK.
He has won numerous prizes in his career including: the Clive and Vera Ramaciotti Award for Excellence in Medical Research; the Pieter Gaillard Award; the William F Newman Award; the Dale Medal; the Clinical Endocrinology Trust Medal; the Lemberg Medal; the Chemofux Research Prize; the Eric Fusman Prize; the Selwyn Smith Prize.
Professor Martin has been a consultant to a number of biotechnology and pharmaceutical companies, including Genentech, Eli Lilly, Servier and Chugai Pharmaceuticals.
He is a past president of the Australian Society for Medical Research and the International Bone and Mineral Society. He is a member of the Editorial Boards of "Journal of Clinical Investigation", "Calcified Tissue International", "Endocrine Reviews", "Bone", "Trends in Endocrinology and Metabolism" and "Endocrinology".
Professor Martin has authored 384 peer-reviewed publications, edited 6 books, and has 165 other publications including reviews, book chapters and editorials.
Professor John W Eaton, BA (Florida State), MA (Florida), MS (Michigan), PhD (Michigan), MD (Linköping).
Professor Eaton is Deputy Director of the James Graham Brown Cancer Centre at the University of Louisville, Louisville, Kentucky.
His previous positions included: Professor, Department of Paediatrics, Baylor College of Medicine, Houston; Professor, Physiology and Cell Biology, Albany Medical College NY; Professor, Laboratory Medicine and Pathology, University of Minnesota Medical School.
He has been a consultant for a number of biotechnology companies, including: Advance Surface Technology; Alcon; Alteon; Biometric Systems; Cerami Consulting; Enzon; Focal; Genzyme; Hunt Mining and Exploration; Infimed Therapeutics; Medtronic; Minntech; Pall Corporation; Pharmacia AB; Shearwater Polymers; Sulver Orthopaedics; SynZyme Technologies; Teltech.
Professor Eaton has published 256 papers in peer-reviewed journals and has edited 7 books.
Professor Simon Charles Gandevia, BScMed(Hons), MBBS, PhD, MD, DSc UNSW, FRACP, FAA.
Professor Gandevia is Deputy Director of the Prince of Wales Medical Research Institute, Sydney. He also is Co-Director of the Spinal Injuries Research Centre at the Institute, a Professor of Medicine at the University of New South Wales, a Clinical Neurophysiologist at Prince Henry and Prince of Wales Hospitals and is an Honorary Professor in the Department of Physiotherapy at the University of Queensland and in the School of Physiotherapy at the University of Sydney. He is a Senior Principal Research Fellow of the National Health and Medical Research Council. He has spent research periods working overseas at McMaster University, Hamilton, Canada, California Institute of Technology, Yale University, the Department of Neurology at the Institute of Psychiatry, London and the Institute of Neurology, London. He is, or has been, a member of the editorial boards of Acta Physiologica Scandinavica, Journal of Physiology, Journal of Applied Physiology and Respiration Physiology.
Professor Gandevia has given more than 70 invited lectures at international scientific conferences. He has received numerous scientific awards and honours, including the Edgeworth David Medal of the Royal Society of New South Wales, the Paxinos-Watson prize of the Australian Neuroscience Society, and the Centenary Medal of Australia. He has trained many PhD scholars and postdoctoral fellows and has hosted 30 scientists undertaking sabbatical research leave in his laboratory. He has authored and co-authored over 260 publications and review articles in scientific journals and textbooks.
Professor Robert M Graham, FAA, MBBS, MD (UNSW), FRACP, FACP, FAHA, FCSANZ.
Professor Graham is the Executive Director of the Victor Chang Cardiac Research Institute in Sydney. He also is Professor of Medicine at the University of New South Wales and has Adjunct appointments at the Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio and in the Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio. His previous appointments have included Associate Professor in Medicine at Harvard Medical School, Professor in the Department of Physiology and Biophysics at Case Western Reserve University, Chairman of the Department of Cardiovascular Biology in the Cleveland Clinic Foundation, and Professor of Medical Biochemistry at the Ohio State University, Columbus, Ohio. He currently is a specialist physician and consultant in cardiorenal diseases at St Vincent’s Hospital in Sydney.
Professor Graham has received many awards and distinctions, including the Gertrude Katser Award of the National Heart Foundation of Australia, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, and the Phyllis Bingemann Award of the National Heart Foundation of Australia. He has given numerous invited awards at major conferences both nationally and internationally.
Professor Graham has been a consultant to a number of biotechnology and pharmaceutical companies, including Pfizer, Eli Lilly, Ciba Corning Diagnostics, Wyeth-Ayerst Pharmaceuticals, Ciba-Geigy, Glaxo, and Bristol-Myers Squibb. He is currently a member of the Editorial Boards of Journal of Molecular and Cellular Cardiology, Molecular Pharmacology and the Journal of Biological Chemistry.
Professor Graham has authored or co-authored around 200 publications.